Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.
about
Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activatorOptimal combination treatment and vascular outcomes in recent ischemic stroke patients by premorbid risk levelThe ThRombolysis in UnconTrolled Hypertension (TRUTH) protocol: an observational study on treatment strategy of elevated blood pressure in stroke patients eligible for IVTFunctional Outcome of Hemorrhagic Transformation after Thrombolysis for Ischemic Stroke: A Prospective StudyRandomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke).Inflammatory and metalloproteinases profiles predict three-month poor outcomes in ischemic stroke treated with thrombolysis.Liver function may play an uneven role in haemorrhagic transformation for stroke subtypes after acute ischaemic stroke.Efficacy and safety of low dose alteplase for intravenous thrombolysis in Asian stroke patients: a meta-analysis.Association between hemorrhagic transformation after endovascular therapy and poststroke seizures.Comparison of application values of CT and MRI in the diagnosis of early Lacunar Infarction.
P2860
Q33719200-F0BB495E-364B-49E5-B159-2A4469FC1191Q35822639-0584720C-CCF8-4DB1-BFBD-11C72C0DB3ACQ35848802-4736D0EC-444E-49EC-BE03-5ECECFF2EC46Q36325806-BA4EE914-3A39-4919-9F17-A0C770B72FFAQ38376753-4D7B9A37-033F-45F8-A136-0ABAB36248D4Q38925343-C51A9F61-E46B-4EA7-BCF5-D8861BBFF77FQ40295166-1F8E0677-0316-434F-96CD-D0798DC92A96Q47147347-B4097ED6-167F-4E72-B568-DD617DF67D7BQ47559786-C53666D0-07D0-40F8-BC2F-6F6EE8B3FFF6Q55341366-B6714492-4AC7-4C97-982C-5D0A44EFC155
P2860
Defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the National Institute of Neurological Disorders and Stroke tissue-type plasminogen activator trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Defining clinically relevant c ...... plasminogen activator trials.
@ast
Defining clinically relevant c ...... plasminogen activator trials.
@en
Defining clinically relevant c ...... plasminogen activator trials.
@nl
type
label
Defining clinically relevant c ...... plasminogen activator trials.
@ast
Defining clinically relevant c ...... plasminogen activator trials.
@en
Defining clinically relevant c ...... plasminogen activator trials.
@nl
prefLabel
Defining clinically relevant c ...... plasminogen activator trials.
@ast
Defining clinically relevant c ...... plasminogen activator trials.
@en
Defining clinically relevant c ...... plasminogen activator trials.
@nl
P2093
P2860
P1433
P1476
Defining clinically relevant c ...... e plasminogen activator trials
@en
P2093
Jeffrey A Gornbein
Neal M Rao
Steven R Levine
P2860
P304
P356
10.1161/STROKEAHA.114.005135
P407
P577
2014-08-05T00:00:00Z